Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Apexigen Inc (APGN)
Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,574
  • Shares Outstanding, K 24,862
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,070 K
  • 60-Month Beta 3.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade APGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.90
  • Most Recent Earnings $-0.24 on 08/10/23
  • Latest Earnings Date 08/17/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 82.38%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +243,758.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3542 +8.72%
on 08/21/23
0.4799 -19.75%
on 07/24/23
-0.0549 (-12.48%)
since 07/21/23
3-Month
0.3542 +8.72%
on 08/21/23
0.6280 -38.68%
on 05/24/23
unch (unch)
since 05/22/23
52-Week
0.3305 +16.52%
on 05/15/23
8.2800 -95.35%
on 09/09/22
-4.7649 (-92.52%)
since 08/22/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AVID : 27.04 (unch)
CPRI : 46.27 (-0.11%)
APGN : 0.3851 (+8.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, RTL, APGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VECT : 16.85 (unch)
RTL : 7.61 (+1.06%)
APGN : 0.3851 (+8.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNL, RTL, APGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GNL : 7.16 (-2.45%)
RTL : 7.61 (+1.06%)
APGN : 0.3851 (+8.48%)
Shareholder Alert: Ademi LLP investigates whether Apexigen, Inc. has obtained a Fair Price in its transaction with Pyxis Oncology

/PRNewswire/ -- Ademi LLP is investigating Apexigen (Nasdaq: APGN) for possible breaches of fiduciary duty and other violations of law in its transaction with...

APGN : 0.3851 (+8.48%)
Is Apexigen, Inc. (APGN) Stock Outpacing Its Medical Peers This Year?

Here is how Apexigen, Inc. (APGN) and ASLAN Pharmaceuticals Ltd. (ASLN) have performed compared to their sector so far this year.

APGN : 0.3851 (+8.48%)
ASLN : 0.7000 (+47.40%)
Are Medical Stocks Lagging Apexigen, Inc. (APGN) This Year?

Here is how Apexigen, Inc. (APGN) and Atara Biotherapeutics (ATRA) have performed compared to their sector so far this year.

APGN : 0.3851 (+8.48%)
ATRA : 0.7605 (-4.34%)
Is Apexigen, Inc. (APGN) Stock Outpacing Its Medical Peers This Year?

Here is how Apexigen, Inc. (APGN) and BeiGene, Ltd. (BGNE) have performed compared to their sector so far this year.

APGN : 0.3851 (+8.48%)
BGNE : 178.48 (-0.67%)
Apexigen Stock Soars After Analyst Rating, Is It Time to Buy?

Apexigen stock is soaring after a bullish analyst rating. This can frequently give penny stocks legitimacy, but only if the stock can hold these gains.

APGN : 0.3851 (+8.48%)
EFHTU : 10.10 (-1.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Apexigen Inc. is a clinical-stage biopharmaceutical company. It focused on discovering and developing a new generation of antibody therapeutics for oncology. Apexigen Inc., formerly known as Brookline Capital Acquisition Corp., is based in SAN CARLOS, Calif.

See More

Key Turning Points

3rd Resistance Point 0.4438
2nd Resistance Point 0.4200
1st Resistance Point 0.4026
Last Price 0.3851
1st Support Level 0.3614
2nd Support Level 0.3376
3rd Support Level 0.3202

See More

52-Week High 8.2800
Fibonacci 61.8% 5.2433
Fibonacci 50% 4.3052
Fibonacci 38.2% 3.3672
Last Price 0.3851
52-Week Low 0.3305

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar